CORR Insights®: What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?

Abstract

1Professor, Department of Orthopaedic Surgery, Ege University, Izmir, Turkey S. Aydogdu, Department of Orthopaedic Surgery, Ege University, Bornova, Izmir, 35100, Turkey, Email: [email protected] This CORR Insights® is a commentary on the article “What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?” by Mert and colleagues available at: DOI: 10.1097/CORR.0000000000002628. The author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request. The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.